10:30 am-12:00 pm,
Saturday, April 1, 2017
|
Auditorium, Level 3 |
Industry-Sponsored Symposia
Pharmacologic Satellite Symposium - Cardiovascular Imaging and Application Value of Contrast Agent - Supported by BraccoSine
|
Xuebo Liu |
Chair |
|
10:30 am-12:00 pm,
Saturday, April 1, 2017
|
Auditorium, Level 3 |
Industry-Sponsored Symposia
Pharmacologic Satellite Symposium - Cardiovascular Imaging and Application Value of Contrast Agent - Supported by BraccoSine
|
Fucheng Sun |
Chair |
|
10:40 am-11:00 am,
Saturday, April 1, 2017
|
Auditorium, Level 3 |
Industry-Sponsored Symposia
Pharmacologic Satellite Symposium - Cardiovascular Imaging and Application Value of Contrast Agent - Supported by BraccoSine
|
Yundai Chen |
Lecturer |
Contrast Medium Angiography ADR Expert Consensus and Iomeron 350 Application |
11:00 am-11:20 am,
Saturday, April 1, 2017
|
Auditorium, Level 3 |
Industry-Sponsored Symposia
Pharmacologic Satellite Symposium - Cardiovascular Imaging and Application Value of Contrast Agent - Supported by BraccoSine
|
Roxana Mehran |
Lecturer |
CIAKI: Prevention and Choice of Contrast Media in Cath Lab |
11:20 am-11:40 am,
Saturday, April 1, 2017
|
Auditorium, Level 3 |
Industry-Sponsored Symposia
Pharmacologic Satellite Symposium - Cardiovascular Imaging and Application Value of Contrast Agent - Supported by BraccoSine
|
Yining Wang |
Lecturer |
Clinical Value of Iomeron400 in Coronary CTA |
11:40 am-12:00 pm,
Saturday, April 1, 2017
|
Auditorium, Level 3 |
Industry-Sponsored Symposia
Pharmacologic Satellite Symposium - Cardiovascular Imaging and Application Value of Contrast Agent - Supported by BraccoSine
|
Shihua Zhao |
Lecturer |
Clinical Value of Contrast Medium in Cardiac MRI |
1:30 pm-3:00 pm,
Saturday, April 1, 2017
|
Auditorium, Level 3 |
Industry-Sponsored Symposia
Pharmacologic Satellite Symposium - Supported by Pfizer
|
Bo Yu |
Chair |
|
1:40 pm-2:00 pm,
Saturday, April 1, 2017
|
Auditorium, Level 3 |
Industry-Sponsored Symposia
Pharmacologic Satellite Symposium - Supported by Pfizer
|
Jingbo Hou |
Lecturer |
Benefit and revelation of intensive lipid lowering |
2:00 pm-2:20 pm,
Saturday, April 1, 2017
|
Auditorium, Level 3 |
Industry-Sponsored Symposia
Pharmacologic Satellite Symposium - Supported by Pfizer
|
Jianping Li |
Lecturer |
Statin therapy strategy in Chinese ACS population, based on ESC guideline |
2:20 pm-2:40 pm,
Saturday, April 1, 2017
|
Auditorium, Level 3 |
Industry-Sponsored Symposia
Pharmacologic Satellite Symposium - Supported by Pfizer
|
Zhongwei Shi |
Lecturer |
Intensive treatment or combination, based on ESC guideline？ |
3:00 pm-5:00 pm,
Saturday, April 1, 2017
|
Auditorium, Level 3 |
Industry-Sponsored Symposia
Pharmacologic Satellite Symposium - Lipid Management of PCI Patients - Supported by MSD
|
Runlin Gao |
Chair |
|
3:10 pm-3:30 pm,
Saturday, April 1, 2017
|
Auditorium, Level 3 |
Industry-Sponsored Symposia
Pharmacologic Satellite Symposium - Lipid Management of PCI Patients - Supported by MSD
|
Juying Qian |
Lecturer |
The optimal LDL-C target: lowering cholesterol level to the newborns |
3:30 pm-3:50 pm,
Saturday, April 1, 2017
|
Auditorium, Level 3 |
Industry-Sponsored Symposia
Pharmacologic Satellite Symposium - Lipid Management of PCI Patients - Supported by MSD
|
Hongbing Yan |
Lecturer |
The standardization management of ACS secondary prevention |
3:50 pm-4:10 pm,
Saturday, April 1, 2017
|
Auditorium, Level 3 |
Industry-Sponsored Symposia
Pharmacologic Satellite Symposium - Lipid Management of PCI Patients - Supported by MSD
|
Ping Ye |
Lecturer |
New progression in combination therapy of lipid-lowering drugs and update in global guidelines |
4:10 pm-4:30 pm,
Saturday, April 1, 2017
|
Auditorium, Level 3 |
Industry-Sponsored Symposia
Pharmacologic Satellite Symposium - Lipid Management of PCI Patients - Supported by MSD
|
Jianjun Li |
Lecturer |
Intensive lipid-lowering makes early benefit-Guidelines for prevention and treatment of dyslipidemia in Chinese adults (2016 version) |
|
Records:55 Pre[1]
[2]
[3]
Next |
